GET THE LATEST ARTICLES BY THE CRITICAL INVESTOR DELIVERED IN YOUR MAILBOX FIRST!

THE CRITICAL INVESTOR NEWSLETTER # 88

Dear subscriber,

Rarely have I seen a junior dealing with a new recovery method this boldly, although especially with specialty metals like lithium this can be a long and problematic journey. Standard Lithium is approaching the task at hand differently from peers, and has apparently convinced lots of investors to provide them with no less than $43M in the last two years, which is no easy feat as lithium product prices were going down since 2018. The last stage pilot plant is being assembled now on site with JV partner Lanxess, the moment of truth is nearing as the company expects to integrate the test results in a PFS during Q1-Q2 2020, which will function as a decision making threshold for Lanxess as well. Read more about it here:

Standard Lithium In Final Stages Of De-risking New Recovery Method; Giant JV Partner Lanxess Will Fully Fund Capex When Successful

Regards,

The Critical Investor

Market Data - 15m delayed

First Hand CEO Interviews, Site Visits, Presentations & Market Analysis:

Real-time knowledge sharing for global investors: CEO.CA

© 2016-2022  CRITICALINVESTOR.EU   All rights reserved.